This retrospective study found no benefit of a disease management program compared with usual care on utilization of secondary prevention pharmacotherapies in postmyocardial infarction patients.
Vicky Chan, PharmD
Advertisement
Articles by Vicky Chan, PharmD
Advertisement
Latest Updated Articles
- Pharmacotherapy After Myocardial Infarction: Disease Management Versus Usual Care
Published: June 7th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
5
